We are monitoring the impact of COVID-19 on Europe Oligonucleotide Synthesis Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 10220
Share on
Share on

Europe Oligonucleotide Synthesis Market Segmentation By Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End-User (Academic, Pharmaceutical, Biotechnology) and Region- Forecast to 2026

Pulished: April, 2021
ID: 10220
Pages: 150

The Europe Oligonucleotide Synthesis Market is foreseen to garner a compound annual growth rate of 13.4% in the outlook period between 2021and 2026.

Recent Developments

  • In February 2019, Thermo Fisher Scientific reached an agreement with BioNTech a German company, under the terms that BioNTech's messenger RNA (mRNA) manufacturing platform will be supported by Thermo Fisher through the supply of nucleotides, enzymes, and other critical raw materials

  • Danaher completed the acquisition of IDT that expanded its courier service of the following day to scientists in Cambridge, Oxford, and London. This service expansion will help IDT to increase its customer base, and also enable the staring, and ending of a project sooner.

Drivers and Restraints of Europe Oligonucleotide Synthesis Market

Europe is a hub for various production industries and construction and the growth of the Oligonucleotide market is growing primarily because of the various research and development activities taking part in Europe. This growth in the industry can also be attributed to the growth in the healthcare sector. Initiatives such as the vaccine for children and prevention for HIV/AIDS have contributed a lot. Synthesized oligonucleotides have various applications in the life sciences, pharmaceutical, and probing of DNA synthesis and sequencing. Clinical trials involving humans is also becoming increasingly popular in the European region, this triggered a demand for the Oligonucleotide industry.

Covid-19 pandemic has had a significant impact on the construction and production sectors in this area. All the activities have come to halt. On top of this, the oligonucleotide synthesis process is very expensive. This cost ineffectiveness may likely be a factor which hinders the growth.

Europe Oligonucleotide Synthesis market has been segmented into the following categories:

On the basis of Product

  1. Primers
  2. Probes
  3. Linkers
  4. Adaptors
  5. Custom
  6. Reagent
  7. Equipment

On the basis of Application

  1. DNA
  2. PCR
  3. RNAi
  4. Research
  5. Therapeutics

On the basis of End Use industry

  1. Biotechnology
  2. Pharmaceutical
  3. Academic
  4. Hospital and Lifesciences

Hospitals are accounted for the largest share of the Oligonucleotide Synthesis market.

They also contribute to the highest revenue generated compared to other end-user segments.

The synthesized oligonucleotide is growing rapidly because of its extensive applications in the life science industries, in addition to that, it finds its applications in therapeutics, genetics, and genomics in the field of research and diagnostics.

These synthetic products are also in high demand from the academic and research institutes are more investments are being made in clinical trials. They are used as PCR primers and probes in DNA sequencing.

Geographical overview and regional presence:

 In the European region, Germany has been investing a lot in the healthcare sector and because of it, the oligonucleotide industry saw significant benefits as clinical trials were increasing and diagnostics applications of the oligo saw a substantial increase.

There are several major players that are asserting their dominance in the Oligonucleotide Synthesis Market in recent years, some of the big names in Europe are:

  1. Agilent Technologies, Inc.

  2. Atdbio Ltd.

  3. LGC Limited

  4. Bio-Synthesis Inc.

  5. Eurofins Genomics

  6. Kaneka Eurogentec S.A.

  7. General Electric

Impact of COVID-19 on the European Oligonucleotide Synthesis Market

Europe was the early hotspot for the COVID-19 pandemic and unlike other industries where businesses were shut due to low demand and lack of trading activities, the Oligonucleotide market saw a substantial increase in demand and production. This is majorly due to the fact that life science and pharmaceutical industries saw a surge in demand during the period. On top of this, A lot of investments were made into research and development of the healthcare sector and vaccine. All this led to the growth of the Oligonucleotide industry during the pandemic and it is expected to last to a foreseeable future.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Primer       

                                5.1.3 Probe        

                                5.1.4 Linker        

                                5.1.5 Adaptor    

                                5.1.6 Custom     

                                5.1.7 Reagent   

                                5.1.8 Equipment              

                                5.1.9  Y-o-Y Growth Analysis, By Product              

                                5.1.10  Market Attractiveness Analysis, By Product          

                                5.1.11  Market Share Analysis, By Product            

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 PCR            

                                5.2.3 DNA           

                                5.2.4 RNAi          

                                5.2.5 Research  

                                5.2.6 Therapeutic            

                                5.2.5 Y-o-Y Growth Analysis, By Application         

                                5.2.6 Market Attractiveness Analysis, By Application       

                                5.2.7 Market Share Analysis, By Application        

                5.3 End User                      

                                5.3.1 Introduction           

                                5.3.2 Academic 

                                5.3.3 Pharmaceutical     

                                5.3.4 Biotechnology       

                                5.3.5 Y-o-Y Growth Analysis, By End User             

                                5.3.6  Market Attractiveness Analysis, By End User          

                                5.3.7  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Application

                                                6.1.3.4 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Application

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Application

                                                6.1.5.4 By End User

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Agilent Technologies                              

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 ATDBio                         

                8.3 Bio-Synthesis                             

                8.4 BioAutomation                         

                8.5 LGC Biosearch Technologies                

                8.6 Eurofins Genomics                  

                8.7 Eurogentec                 

                8.8 GeneDesign                               

                8.9 GE Healthcare                           

                8.10 GenScript                  

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global,Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

  • Segment-level analysis in terms of by product,,by application,along with market size forecasts and estimations to detect key areas of industry growth in detail

  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics

  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis

  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development

  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment

  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

  1. EUROPE Oligonucleotide Synthesis Market By Region, From 2021-2026 ( USD Billion )

  2. EUROPE Oligonucleotide Synthesis Market By Product, From 2021-2026 ( USD Billion )

  3. EUROPE Primer Market By Region, From 2021-2026 ( USD Billion )

  4. EUROPE Probe Market By Region, From 2021-2026 ( USD Billion )

  5. EUROPE Linker Market By Region, From 2021-2026 ( USD Billion )

  6. EUROPE Adaptor Market By Region, From 2021-2026 ( USD Billion )

  7. EUROPE Custom Market By Region, From 2021-2026 ( USD Billion )

  8. EUROPE Reagent Market By Region, From 2021-2026 ( USD Billion )

  9. EUROPE Equipment Market By Region, From 2021-2026 ( USD Billion )

  10. EUROPE Oligonucleotide Synthesis Market By Application, From 2021-2026 ( USD Billion )

  11. EUROPE PCR Market By Region, From 2021-2026 ( USD Billion )

  12. EUROPE DNA Market By Region, From 2021-2026 ( USD Billion )

  13. EUROPE RNAi Market By Region, From 2021-2026 ( USD Billion )

  14. EUROPE Research Market By Region, From 2021-2026 ( USD Billion )

  15. EUROPE Therapeutic Market By Region, From 2021-2026 ( USD Billion )

  16. EUROPE Oligonucleotide Synthesis Market By End-User, From 2021-2026 ( USD Billion )

  17. EUROPE Academic Market By Region, From 2021-2026 ( USD Billion )

  18. EUROPE Pharmaceutical Market By Region, From 2021-2026 ( USD Billion )

  19. EUROPE Biotechnology Market By Region, From 2021-2026 ( USD Billion )

 

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 2500

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample